Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Shukra Pharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price

₹67.6

2024-10-29

Market Capitalization

₹108.7 M

2024-10-29

Revenue

₹325.9 M

FY, 2025

CreditSafe Score

?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

INRFY, 2018FY, 2019FY, 2020FY, 2021FY, 2022FY, 2023FY, 2024FY, 2025
Revenue15.6M13.7M44.5M112.0M204.9M588.3M745.7M325.9M
Cost of goods sold9.5M9.9M30.0M27.7M103.5M453.2M444.9M81.1M
Gross profit43.9M46.7M88.4M87.4M101.9M146.5M323.4M272.0M
Gross profit margin, %341.2%198.8%78.0%49.7%24.9%43.4%83.5%
Operating expense total27.8M30.2M73.0M69.8M72.5M81.5M106.8M117.5M
Depreciation and amortization7.4M9.6M14.8M14.7M16.6M18.4M20.5M30.0M
EBITDA16.2M16.5M15.4M17.5M29.3M65.0M216.6M154.6M
EBITDA margin, %120.5%34.6%15.7%14.3%11.0%29.0%47.4%
EBIT9.8M7.2M1.6M844.0K12.7M46.6M196.1M124.5M
EBIT margin, %52.6%3.7%0.8%6.2%7.9%26.3%38.2%
Interest income53.0K51.0K85.0K467.0K314.0K639.0K5.6M14.8M
Interest expense403.0K6.0K21.0K333.0K2.9M2.8M2.9M5.9M
Pre tax profit9.5M7.2M1.7M978.0K10.2M44.4M198.8M133.4M
Income tax expense4.2M2.6M1.4M(903.0K)2.7M352.0K13.5M37.6M
Net Income5.3M4.6M356.0K1.9M7.5M44.1M185.4M95.8M

Footer menu